Correction to: International Journal of Clinical Oncology (2022) 27:1828–1838
https://doi.org/10.1007/s10147-022-02232-7
In the original publication, under section: Secondary end points, the sentence starting with: “KM estimated…” should read as:
Anzeige
KM estimated median DoR was not reached (95% CI 13.9–not reached) in patients who had confirmed responses.
In Results section, under heading Secondary end points, the sentence starting with: "Among..." should read as: Among the 31 patients with confirmed response by IRC, median time to response was 1.8 months (range, 0.95–12.9). In Table 2 the value of the entry: Duration of response, months, median (range) has been updated. The revised Table 2 is given in this Correction.
Table 2
Rates of systemic and intracranial objective response by IRC assessment
TKI-naive cohort n = 32 | |
|---|---|
All patients Confirmed ORR | |
n (%) | 31 (97) |
95% CI | 83.8–99.9 |
Best overall response, n (%) | |
Confirmed complete response | 2 (6) |
Confirmed partial response | 29 (91) |
Stable disease | 0 |
Not evaluable | 1 (3) |
Time to response, months, median (range) | 1.8 (0.95, 12.9) |
Duration of response, months, median (range) | NR (13.9, NR) |
Patients with measurable CNS metastases at baseline | n = 5 |
Confirmed intracranial ORR | |
n (%) | 2 (40) |
95% CI | 5.3–85.3 |
Best overall intracranial response, n (%) | |
Confirmed complete response | 0 |
Confirmed partial response | 2 (40) |
Stable disease | 3 (60) |
Not evaluable | 0 |
The original publication has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.